IDR 2600.0
(-1.52%)
Year | Operating Expenses | Operating Expenses Growth |
---|---|---|
2023 | 956.86 Billion IDR | -0.57% |
2022 | 880.43 Billion IDR | 1.57% |
2021 | 866.78 Billion IDR | 17.37% |
2020 | 738.48 Billion IDR | -9.84% |
2019 | 819.07 Billion IDR | 7.33% |
2018 | 763.11 Billion IDR | 8.27% |
2017 | 704.84 Billion IDR | 6.18% |
2016 | 663.79 Billion IDR | 8.39% |
2015 | 612.4 Billion IDR | 11.18% |
2014 | 550.81 Billion IDR | 7.8% |
2013 | 510.96 Billion IDR | 0.0% |
Year | Operating Expenses | Operating Expenses Growth |
---|---|---|
2024 Q1 | 201.6 Billion IDR | -29.11% |
2024 Q3 | 180.34 Billion IDR | -14.44% |
2024 Q2 | 210.77 Billion IDR | 4.55% |
2023 Q2 | 260.73 Billion IDR | 16.12% |
2023 Q1 | 224.53 Billion IDR | -9.03% |
2023 FY | 875.42 Billion IDR | -0.57% |
2023 Q4 | 284.38 Billion IDR | 31.66% |
2023 Q3 | 216 Billion IDR | -17.16% |
2022 Q2 | 229.55 Billion IDR | 11.97% |
2022 Q1 | 205.02 Billion IDR | -22.77% |
2022 FY | 880.43 Billion IDR | 1.57% |
2022 Q3 | 199.01 Billion IDR | -13.3% |
2022 Q4 | 246.83 Billion IDR | 24.03% |
2021 Q2 | 202.06 Billion IDR | 3.48% |
2021 Q3 | 204 Billion IDR | 0.96% |
2021 Q4 | 265.46 Billion IDR | 30.13% |
2021 FY | 866.78 Billion IDR | 17.37% |
2021 Q1 | 195.25 Billion IDR | -6.99% |
2020 Q4 | 209.93 Billion IDR | 35.04% |
2020 Q1 | 193.31 Billion IDR | -8.26% |
2020 Q2 | 179.77 Billion IDR | -7.0% |
2020 Q3 | 155.45 Billion IDR | -13.53% |
2020 FY | 738.48 Billion IDR | -9.84% |
2019 Q3 | 217.37 Billion IDR | 6.54% |
2019 Q4 | 210.72 Billion IDR | -3.06% |
2019 Q2 | 204.04 Billion IDR | 9.15% |
2019 Q1 | 186.93 Billion IDR | -12.55% |
2019 FY | 819.07 Billion IDR | 7.33% |
2018 Q4 | 213.75 Billion IDR | 8.87% |
2018 Q3 | 196.34 Billion IDR | 10.62% |
2018 Q2 | 177.49 Billion IDR | 1.12% |
2018 Q1 | 175.52 Billion IDR | -5.99% |
2018 FY | 763.11 Billion IDR | 8.27% |
2017 Q4 | 186.7 Billion IDR | 4.56% |
2017 FY | 704.84 Billion IDR | 6.18% |
2017 Q3 | 178.55 Billion IDR | -5.77% |
2017 Q2 | 189.49 Billion IDR | 26.25% |
2017 Q1 | 150.09 Billion IDR | -10.42% |
2016 Q1 | 147.64 Billion IDR | -1.36% |
2016 Q2 | 172.88 Billion IDR | 17.09% |
2016 Q3 | 175.72 Billion IDR | 1.64% |
2016 Q4 | 167.54 Billion IDR | -4.66% |
2016 FY | 663.79 Billion IDR | 8.39% |
2015 Q2 | 145.82 Billion IDR | 0.0% |
2015 Q4 | 149.68 Billion IDR | 0.0% |
2015 FY | 612.4 Billion IDR | 11.18% |
2015 Q1 | 145.82 Billion IDR | 0.0% |
2015 Q3 | 149.68 Billion IDR | 2.64% |
2014 FY | 550.81 Billion IDR | 7.8% |
2013 FY | 510.96 Billion IDR | 0.0% |
Name | Operating Expenses | Operating Expenses Difference |
---|---|---|
PT Diagnos Laboratorium Utama Tbk | 72.8 Billion IDR | -1214.346% |